Sixty patients with silicosis were examined by right heart catheterization and lung function tests during 1958-1966. In the 12-20 years follow-up the information was received of 57 patients (95%). 38 patients died (66.6%), 26 of them of the sequelae of silicosis. The death rate and the length of survival are related to mean pulmonary artery pressure, pressure gradient across pulmonary vascular bed, pulmonary vascular bed, pulmonary vascular resistance (PVR), arterial oxygen saturation (SaO2), vital capacity (VC) and forced expiratory volume (FEV). 12-year mortality in patients with pulmonary hypertension at rest was 81.3%, in contrast to 40.2% in the other patients. No patient with PVR higher than 2.55 u. survived. No patients with SaO2 lower than 89% survived 10 years. Patients with VC higher than 4000 ml at the initial examination are still living. By the method of discriminating analysis 2 main factors determining the prognosis were identified: pulmonary artery pressure and FEV 1".

Download full-text PDF

Source

Publication Analysis

Top Keywords

pulmonary vascular
12
pulmonary hypertension
8
pulmonary artery
8
artery pressure
8
vascular bed
8
bed pulmonary
8
pulmonary
7
patients
7
long-term prognosis
4
prognosis pulmonary
4

Similar Publications

Hypoxia is a major cause of pulmonary hypertension (PH) worldwide, and it is likely that interstitial pulmonary macrophages contribute to this vascular pathology. We observed in hypoxia-exposed mice an increase in resident interstitial macrophages, which expanded through proliferation and expressed the monocyte recruitment ligand CCL2. We also observed an increase in CCR2+ macrophages through recruitment, which express the protein thrombospondin-1 that functionally activates TGF-beta to cause vascular disease.

View Article and Find Full Text PDF

Fibrotic hypersensitivity pneumonitis (f-HP) is an interstitial lung disease in which various antigens in susceptible individuals may play a pathogenetic role. This study evaluates the role of transbronchial lung cryobiopsy (TBLC) and bronchoalveolar lavage (BAL) in identifying a UIP-like pattern and its association with fibrosis progression. We conducted a multicentre retrospective cohort study of patients diagnosed with f-HP who underwent BAL and TBLC between 2011 and 2023.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICIs) combined with anti-vascular endothelial growth factor (VEGF) have been the standard first-line treatment of hepatocellular carcinoma (HCC). However, the efficacy of this combination in post-line treatment is still unknown. This study aimed to evaluate the efficacy and safety of the combination of anti-PD-L1 envafolimab and novel humanized anti-VEGF suvemcitug as second-line treatment for patients with HCC.

View Article and Find Full Text PDF

Screening for pulmonary nodules (PN) using low-dose CT has proven effective in reducing lung cancer (LC) mortality. However, current treatments relying on follow-up and surgical excision fail to fully address clinical needs. Pathological angiogenesis plays a pivotal role in supplying oxygen necessary for the progression of PN to LC.

View Article and Find Full Text PDF

Pulmonary embolism (PE) can result in high mortality. Early risk stratification and treatment are critical for individualized management. In patients with intermediate-high-risk (IHR) PE, guidelines recommend to consider a percutaneous catheter-directed treatment (CDT).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!